  0 Table of Contents |
 1 Home |
   1.1 Changes |
| 1.2 Dependencies |
| 1.3 References |
| 1.4 Adapting Guidelines for Country use |
 1.5 License |
| 2 Business Requirements |
| 2.1 Concepts |
| 2.2 Generic Personas |
| 2.3 User Scenarios |
| 2.4 Business Processes |
| 2.5 Data Dictionary |
| 2.6 Decision-support logic |
| 2.7 Indicator and Performance Metrics |
| 2.8 Functional Requirements |
| 2.9 Non-functional Requirements |
| 3 Data Models and Exchange |
| 3.1 System Actors |
| 3.2 Sequence Diagrams |
| 3.3 Transactions |
| 3.4 Indicators and Measures |
| 3.5 Codings |
| 4 Deployment |
| 4.1 Security and Privacy Considerations |
| 4.2 Testing |
| 4.3 Test Data |
| 4.4 Reference Implementations |
| 4.5 Downloads |
 5 Indices |
 5.1 Artifact Index |
| 5.1.1 IMMZ.D2.DT.Measles.Contraindication |
| 5.1.2 IMMZ.D2.DT.Measles.Eval |
| 5.1.3 IMMZ.D2.DT.Measles.MR |
| 5.1.4 IMMZ.D2.DT.Measles Low Transmission |
| 5.1.5 IMMZ.D2.DT.Measles MCV Dose 0 |
| 5.1.6 IMMZ.D2.DT.Measles MCV Dose 0 |
| 5.1.7 IMMZ.D2.DT.Measles Ongoing Transmission |
| 5.1.8 IMMZ.D5.DT.Measles.Contraindication |
| 5.1.9 IMMZ.DT.Immunization Strategy |
| 5.1.10 IMMZ.IND.08 Logic |
| 5.1.11 IMMZ.IND.12 Logic |
| 5.1.12 IMMZ.IND.13 Logic |
| 5.1.13 IMMZCommon |
| 5.1.14 IMMZConcepts |
| 5.1.15 IMMZConfig |
| 5.1.16 IMMZD2DTMeaslesDose0Logic |
| 5.1.17 IMMZD2DTMeaslesLogic |
| 5.1.18 IMMZD2DTMeaslesLTLogic |
| 5.1.19 IMMZD2DTMeaslesOTLogic |
| 5.1.20 IMMZD2DTMeaslesSupplementaryLogic |
| 5.1.21 IMMZD5DTMeaslesCILogic |
| 5.1.22 IMMZElements |
| 5.1.23 IMMZEncounterElements |
| 5.1.24 IMMZIndicatorElements |
| 5.1.25 IMMZVaccineLibrary |
| 5.1.26 WHOCommon |
| 5.1.27 WHOConcepts |
| 5.1.28 WHOElements |
| 5.1.29 WHOEncounterElements |
| 5.1.30 A record of an immunization, with a given product |
| 5.1.31 A Vaccine product |
| 5.1.32 An order for an actual product |
| 5.1.33 An order for immunization (for a disease, not a specific product) |
| 5.1.34 SGAdministeredProduct |
| 5.1.35 SGMedicationClassification |
| 5.1.36 ARV Drugs values |
| 5.1.37 Birthweight valueset |
| 5.1.38 Country ValueSet |
| 5.1.39 HIV status values |
| 5.1.40 Immunization Status Codes |
| 5.1.41 Immunocompromised valueset |
| 5.1.42 IMMZ.C.DE5 ValueSet for Sex |
| 5.1.43 IMMZ.D1.DE1 CodeSystem for Immunization status |
| 5.1.44 IMMZ.D1.DE10 ValueSet for HIV Status |
| 5.1.45 IMMZ.D1.DE5 values for Reason Not Done |
| 5.1.46 IMMZ.D4.DE161 ValueSet for Potential Contraindications |
| 5.1.47 IMMZ.Z.DE9 ValueSet for Measles Vaccines |
| 5.1.48 Measles Vaccine Type ValueSet |
| 5.1.49 MeaslesVaccine Products ValueSet |
| 5.1.50 Negative Test Results |
| 5.1.51 Positive Test Result valuest |
| 5.1.52 Pregnancy status values |
| 5.1.53 Set of live attenuated vaccines |
| 5.1.54 Vaccine Type ValueSet |
| 5.1.55 ICD-11 |
| 5.1.56 Immunizations Concepts CodeSystem |
| 5.1.57 Vaccine Product codes CodeSet |
| 5.1.58 ConceptMap to and from ICD-11 |
| 5.1.59 ConceptMap to and from Immunization Concepts to administrative gender |
| 5.1.60 ConceptMap to and from LOINC |
| 5.1.61 ConceptMap to and from SNOMED |
| 5.1.62 IMMZ.IND.08 Immunization coverage for Measles containing vaccine (Estimated Denominator) |
| 5.1.63 IMMZ.IND.12 Measles indicator for first dose |
| 5.1.64 IMMZ.IND.13 Measles indicator for second dose |
| 5.2 Mappings |